1 / 57

Acetaminophen and Salicylates Toxicity and Management

Acetaminophen and Salicylates Toxicity and Management. Joseph Rella, MD Emergency Medicine NJMS. Analgesics Cosmetics and personal care products Cleaning Substances Sedative-Hypnotics-Antipsychotics Foreign bodies. 284,906 214,780 214,091 141,150 120,752.

cosette
Download Presentation

Acetaminophen and Salicylates Toxicity and Management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Acetaminophen and SalicylatesToxicity and Management Joseph Rella, MD Emergency Medicine NJMS

  2. Analgesics Cosmetics and personal care products Cleaning Substances Sedative-Hypnotics-Antipsychotics Foreign bodies 284,906 214,780 214,091 141,150 120,752 Substances most frequently involved in Human exposures Bronstein AC, Spyker DA, Cantilena LR, et al 2006 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. ClinToxicol 2007;45:815-917

  3. Sedatives-Hypnotics-Antipsychotics Opioids Cardiovascular drugs Antidepressants Stimulants and street drugs Acetaminophen (alone or combo) 382 307 252 210 203 352 Categories with the largest number of deaths Bronstein AC, Spyker DA, Cantilena LR, et al 2006 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. ClinToxicol 2007;45:815-917

  4. American Association of Poison Control Centers 2006 Annual Report In the group Analgesics, Acetaminophen and Salicylate make up 40% of the cases reported.

  5. AcetaminophenN – acetyl – p – aminophenol (APAP)

  6. Acetaminophen • First synthesized and used in the late 1800’s • “Rediscovered” in 1950 • A metabolite of phenacetin, it was not widely accepted in the medical community until the 1970’s

  7. Got Acetaminophen? Caplets: Arthritis Foundation Pain Reliever Aspirin Free Aspirin Free Pain Relief Aspirin Free Anacid Maximum Strength Atasol Atasol Forte Genapap Extra Strength Genebs Extra Strength Caplets Panadol Panadol Junior Strength Tapanol Extra Strength Tylenol Arthritis Extended Relief Tylenol Caplets Capsules: Dapacin Meda Cap Elixir: Aceta Genapap Children's Mapap Children's Oraphen-PD Ridenol Silapap Children's Tylenol Children's Gelcaps: Aspirin Free Anacid Maximum Strength Tapanol Extra Strength Tylenol Extra Strength Oral Liquid/Syrup: Atasol Children's Acetaminophen Elixir Drops Halenol Children's Panadol Children's Pediatrix Tempra Tempra 2 Syrup Tempra Children's Syrup Tylenol Extra Strength Oral Solution: Acetaminophen Drops Apacet Atasol Children's Acetaminophen Oral Solution Genapap Infants' Drops Mapap Infant Drops Panadol Infants' Drops Pediatrix PMS-Acetaminophen Silapap Infants Tempra 1 Tylenol Infants' Drops Uni-Ace Oral Suspension: Tylenol Children's Suspension Tylenol Infants' Suspension Sprinkle Capsules: Feverall Children's Feverall Junior Strength Suppositories: Abenol 120, 325, 650 mg Acephen Acetaminophen Uniserts Children's Feverall Infant's Feverall Junior Strength Feverall Neopap Tablets: Aceta A.F. Anacin A.F. Anacin Extra Strength Apo-Acetaminophen Aspirin Free Pain Relief Aspirin Free Anacin Maximum Strength Atasol Atasol Forte Extra Strength Acetaminophen Fem-Etts Genapap Genapap Extra Strength Genebs Genebs Extra Strength Mapap Regular Strength Mapap Extra Strength Maranox Meda Tab Panadol Redutemp Regular Strength Acetaminophen Tapanol Regular Strength Tapanol Extra Strength Tempra Tylenol Regular Strength Tylenol Extra Strength Tylenol Junior Strength Tylenol Tablets 325 mg, 500 mg Tablets, Chewable: Apacet Children's Chewable Acetaminophen Children's Genapap Children's Panadol Children's Tylenol Tempra Tempra 3 Tylenol Chewable Tablets Fruit Tylenol Junior Strength Chewable Tablets Fruit (OTC)Acetaminophen, buffered Acetaminophen, buffered (Bromo Seltzer) Acetaminophen, buffered

  8. UDP-glucuronosyl- transferase Urine 50% <5% 40% Acetaminophen Phenosulfotransferase Acetaminophen glucuronide CytoP450 5-15% Acetaminophen sulfate Glutathione (GSH) Metabolism N-acetylparabenzoquinoneimine Acetaminophen glutathione conjugate

  9. Overdose! UDP-glucuronosyl- transferase Urine Saturated <5% Acetaminophen Phenosulfotransferase CytoP450 39% Glutathione (GSH) Acetaminophen glutathione conjugate Acetaminophen sulfate NAPQI Binding to cellular proteins leading to hepatic and renal injury N-acetylparabenzoquinoneimine

  10. NAPQI Toxicity • A highly reactive electrophile • Covalently binds to and arylates critical cell proteins leading to cell death • This process is not inevitable • This process may be prevented, interrupted, and reversed

  11. Organ Toxicity • NAPQI-derived • Liver – begins in zone 3 (centrilobular) • Renal – Acute Tubular Necrosis • Multiorgan failure • Heart, kidney • Poorly defined • Brain • Pancreas

  12. Anatomy of a Liver Lobule

  13. Normal Liver

  14. Cirrhosis Centilobular necrosis

  15. Most people took less than they say they did, except for those who took more. Number of people amount

  16. Clinical evidence of toxicity • Phase 1 – 0-24 hours • Nausea, vomiting, nothing • Phase 2 – 24-72 hours • RUQ pain, elevated liver enzymes, prolonged PT • Phase 3 – 72-96 hours • Hepatic necrosis, encephalopathy, coagulopathy, ATN • Phase 4 – 4 days- 2 weeks • If damage is not irreversible, complete resolution of hepatic dysfunction will occur

  17. Toxic Dose • Acute overdose is usually considered to be a single ingestion • Generally, 7.5 gm in an adult or 150 mg/kg in a child are the lowest threshold capable of toxicity

  18. Risk Assessment • Fatalities are relatively uncommon • The overwhelming majority of APAP exposures result in no toxicity • The antidote is very safe

  19. Risk Assessment • Plasma GSH is not related to hepatic GSH availability • Protein adducts (NAPQI bound to hepatic proteins) are measurable, but follow hepatic necrosis

  20. Rumack-Matthew Nomogram 500 200 Potential for Toxicity 150 100 50 Toxicity Unlikely APAP concentration mcg/mL 10 4 8 16 12 20 24 Time after ingestion

  21. Validation of the Nomogram • Smilkstein, Knapp, Kulig, Rumack. Efficacy of oral N-Acetylcysteine in the treatment of acetaminophen overdose: Analysis of the national multicenter study. N Engl J Med 1988;319:1557-1562 • 11,000 patients enrolled • 2,200 patients treated • 8 hour treatment window

  22. Laboratory predictors of poor prognosis:The King’s College Criteria • pH < 7.30 Or • PT > 100sec, Creatinine > 3.4 mg/dL, grade III+ Encephalopathy ( vitamin k vs. FFP) PPV= 98% NPV=82%

  23. Laboratory predictors of poor prognosis:The Clichy Criteria • Factor V < 50% of normal • Age • Absence of HBsAg • Α fetoprotein level PPV=90% NPV=94%

  24. Laboratory predictors of poor prognosis:Serum Phosphorus Chung PY, Sitrin MD, Te HS. Serum phosphorus level predict clinical outcome in fulminant hepatic failure. Liver Transplantation. 2003;9:248-253

  25. GI Decontamination • Very rapid GI absorption • Activated Charcoal • Very early presentation • Co-ingestants • Adsorbs to NAC

  26. N-Acetylcysteine therapy • Prevents toxicity by limiting NAPQI formation • Increases capacity to detoxify formed NAPQI

  27. UDP-glucuronosyl- transferase Urine 50% <5% 40% Acetaminophen Phenosulfotransferase Acetaminophen glucuronide CytoP450 5-15% Acetaminophen sulfate Glutathione (GSH) NAC-Good for what ails you NAC NAC NAC NAC

  28. Late NAC Therapy • Decreased hepatotoxicity when treatment begins 16-24 hours post ingestion Smilkstein, Knapp, Kulig, Rumack. N-Acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 1989;320:1418 • IV NAC begun after onset of fulminant hepatic failure decreased need for vasopressors, and decreased incidence of cerebral edema and death Keays, Harrison, Wendon, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective trial. Br Med J 1991;303:1026-1029

  29. Other Benefits of NAC • Improved oxygen delivery and utilization in extrahepatic organs • Helps preserve cerebral blood flow • Possibly due to mediation of microvascular tone

  30. Treat everyone the Same? • Only the 17dose oral NAC regimen has been extensively studied – in the US • 140 mg/kg loading dose – 17 doses 70 mg/kg po • Shorter courses of therapy • Longer courses of therapy

  31. No vomiting Consistent delivery Only route studied for fulminant hepatic failure Pregnancy? Anaphylactoid response No first-pass effect More costly No guarantee of sterility or pyrogen free What about IV NAC? Con Pro

  32. The long-awaited… • 150 mg/kg in 200mL D5W over 15min • 50mg/kg in 500mL D5W over 4 hours • 100 mg/kg in 1L D5W over 16 hours

  33. Non-acute ingestions • Hepatotoxicity is rare • Usually seen in pediatric population • Poor label-reading • Mom & Dad…

  34. Case Examples • Acute ingestion 4-hour level 155mcg/mL • Acute ingestion 4-hour level 149mcg/mL • Acute ingestion 1-hour presentation • Acute ingestion 6-hour presentation • Unknown time of ingestion • Unknown time of ingestion, AST 2500

  35. Salicylates Acetyl salicylic acid

  36. Got Salicylates? Apo-Asa Asaphen Aspergum Aspirin Aspirin Regimen Bayer 81 mg with Calcium Bayer Children's Aspirin Easprin Ecotrin Caplets and Tablets Ecotrin Maximum Strength Caplets and Tablets Empirin Entrophen Excedrin Geltabs Genprin Genuine Bayer Aspirin Caplets and Tablets Halfprin 8-Hour Bayer Timed-Release Caplets Maximum Bayer Aspirin Caplets and Tablets MSD Enteric Coated ASA Norwich Extra Strength Novasen St. Joseph Adult Chewable Aspirin Therapy Bayer Caplets ZOR-prin (OTC) (Easprin and ZOR-prin are Rx) Acetylsalicylic acid, buffered Acetylsalicylic acid, buffered (Ascriptin Regular Strength, Bufferin) Acetylsalicylic acid, buffered Alka-Seltzer with Aspirin Alka-Seltzer with Aspirin (flavored) Alka-Seltzer Extra Strength with Aspirin Arthritis Pain Formula Ascriptin Regular Strength Ascriptin A/D Bayer Buffered Buffered Aspirin Bufferin Buffex Cama Arthritis Pain Reliever Magnaprin Magnaprin Arthritis Strength Captabs Tri-Buffered Bufferin Caplets and Tablets

  37. Pharmacokinetics • pKa of 3.5 • Peak serum levels in 30 minutes • Absorbed well in stomach and intestine

  38. Toxicokinetics • Above 30 mg/dL • Delayed absorption from pylorospasm, bezoar formation • Peak serum levels 4 – 6 or more hours • At toxic levels, elimination routes are saturated • Decreased fraction protein bound*

  39. Toxicity • Primary respiratory stimulant • Tinnitus • Gastrointestinal upset and pylorospasm • Diaphoresis • Mental status changes • Acute Lung Injury • Increased brain utilization of glucose • Metabolic acidosis

  40. Methyl salicylate Acetyl Salicylic acid 2.5% Absorbed, Protein binding Urine pH Salicylic acid Salicyluric acid Gentisic acid Ether glucuronide Ester glucuronide Metabolism

  41. Overdose! Methyl salicylate Acetyl Salicylic acid 2.5% More ASA Absorbed Decreased Protein binding Urine pH Salicylic acid SATURATED Salicyluric acid Gentisic acid Ether glucuronide Ester glucuronide

  42. Normal Energy Generation Kreb’s Cycle Glycolysis Glucose Pyruvate Pyruvate decarboxylase CO2 Oxidative Phosphorelation NADH2 H2O ATP

  43. Salicylate Uncoupling ATP Kreb’s Cycle Glycolysis Glucose Pyruvate Pyruvate decarboxylase CO2 Lactate Oxidative Phosphorelation NADH2 H2O SALICYLATES ATP

  44. Methanol Uremia DKA, SKA, AKA Paraldehyde INH, Iron, Infection Lactate Ethylene glycol Salicylates MUDPILES

  45. Does Serum Level Correlate with Acute Toxicity? • Serum levels not tissue levels • Done nomogram – 1960 • Methylsalicylate – rapid deterioration • Follow levels closely with: arterial pH, clinical condition • Serum levels > 100mg/dL

  46. Chronic Salicylism • Most common in the elderly-unintentional • May include any sign consistent with acute toxicity • May also present as: • Delerium • Dementia • Encephalopathy of unknown origin • Congestive heart failure

  47. Rapid ASA Confirmation + FeCl2 Salicylic Acid (Purple colored complex)

  48. Management • Decontamination • Blood work • ABG • ASA level – mg/dL • Electrolytes – K+, BUN/Cr • Fluid resuscitation - a return to euvolemia • Electrolyte repletion • An appropriate cry for help?

  49. GI Decontamination • Activated Charcoal • Multiple Dose Activated Charcoal (MDAC) • Whole Bowel Irrigation (enteric coated)

More Related